PPBT
Purple Biotech
PPBT
PPBT
11 hedge funds and large institutions have $2.17M invested in Purple Biotech in 2020 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
11
Holders Change
+6
Holders Change %
+120%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
2
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
O
OrbiMed
New York
|
$1.06M |
2 |
CH
CVI Holdings
Wilmington,
Delaware
|
$605K |
3 |
Morgan Stanley
New York
|
$171K |
4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
$145K |
5 |
Renaissance Technologies
New York
|
$116K |
Top Sellers
No sellers this quarter